Price Information
| Cat No. | Plasmid Name | Availability | Add to cart |
|---|---|---|---|
| V010426 | pLVX-Puro | In stock, instant shipping |
Buy one, get one free! |
Two tubes of lyophilized plasmid will be delivered, each tube is about 5µg.
Basic Vector Information
The pLVX-Puro is a lentiviral expression vector with the constitutive CMV promoter and a puromycin resistance marker.
- Vector Name:
- pLVX-Puro
- Antibiotic Resistance:
- Ampicillin
- Length:
- 8055 bp
- Type:
- Viral Expression & Packaging Vectors
- Replication origin:
- ori
- Source/Author:
- Clontech
- Copy Number:
- High copy number
- Promoter:
- mPGK
pLVX-Puro vector Map
Plasmid Protocol
1. Centrifuge at 5,000×g for 5 min.
2. Carefully open the tube and add 20 μl of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin to concentrate the liquid at the bottom. Speed is less than 5000×g.
5. Store the plasmid at -20 ℃.
6. The concentration of plasmid re-measurement sometimes differs from the nominal value, which may be due to the position of the lyophilized plasmid in the tube, the efficiency of the re-dissolution, the measurement bias, and adsorption on the wall of the tube, therefore, it is recommended to transform and extract the plasmid before using it
General Plasmid Transform Protocol
1. Take one 100μl of the competent cells and thaw it on ice for 10min, add 2μl of plasmid, then ice bath for 30min, then heat-shock it at 42℃ for 60s, do not stir, and then ice bath for 2min.
2. Add 900μl of LB liquid medium without antibiotics, and incubate at 37℃ for 45min (30℃ for 1-1.5 hours) with 180rpm shaking.
3. Centrifuge at 6000rpm for 5min, leave only 100μl of supernatant to resuspend the bacterial precipitate and spread it onto the target plasmid-resistant LB plate.
4. Invert the plate and incubate at 37℃ for 14h, or at 30℃ for 20h.
5. Pick a single colony into LB liquid medium, add the corresponding antibiotics, incubate at 220rpm for 14h, and extract the plasmid according to the experimental needs and the instructions of the plasmid extraction kit.
References
- Li X, Chen Z, Li X, Wang H. In vitro analysis of the role of tumor necrosis factor‑stimulated gene‑6 in keloid. Mol Med Rep. 2019 Feb;19(2):919-926. doi: 10.3892/mmr.2018.9767. Epub 2018 Dec 14. PMID: 30569148; PMCID: PMC6323212.
- Abbasi Pashaki P, Rahim F, Habibi Roudkenar M, Razavi-Toosi S, Ebrahimi A. MicroRNA Tough Decoy Knockdowns miR-195 and Represses Hypertrophy in Chondrocytes. Appl Biochem Biotechnol. 2020 Jul;191(3):1056-1071. doi: 10.1007/s12010-020-03229-6. Epub 2020 Jan 20. PMID: 31956957.
- Han X, Shi F, Guo S, Li Y, Wang H, Song C, Wu S. LINC02086 promotes cell viability and inhibits cell apoptosis in breast cancer by sponging miR-6757-5p and up-regulating EPHA2. World J Surg Oncol. 2023 Nov 27;21(1):371. doi: 10.1186/s12957-023-03245-w. PMID: 38008720; PMCID: PMC10680215.
pLVX-Puro vector Sequence
LOCUS Exported 8055 bp DNA circular SYN 02-SEP-2024
DEFINITION Exported.
ACCESSION V010426
VERSION .
KEYWORDS pLVX-Puro
SOURCE synthetic DNA construct
ORGANISM synthetic DNA construct
REFERENCE 1 (bases 1 to 8055)
AUTHORS Clontech
TITLE Direct Submission
REFERENCE 2 (bases 1 to 8055)
TITLE Direct Submission
REFERENCE 3 (bases 1 to 8055)
AUTHORS .
TITLE Direct Submission
COMMENT SGRef: number: 1; type: "Journal Article"
COMMENT SGRef: number: 2; type: "Journal Article"
FEATURES Location/Qualifiers
source 1..8055
/mol_type="other DNA"
/organism="synthetic DNA construct"
LTR 1..634
/label=3' LTR
/note="3' long terminal repeat (LTR) from HIV-1"
misc_feature 681..806
/label=HIV-1 Psi
/note="packaging signal of human immunodeficiency virus
type 1"
misc_feature 1303..1536
/label=RRE
/note="The Rev response element (RRE) of HIV-1 allows for
Rev-dependent mRNA export from the nucleus to the
cytoplasm."
CDS 1721..1765
/label=gp41 peptide
/note="antigenic peptide corresponding to amino acids 655
to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
al., 2013)"
CDS 1914..1955
/label=Protein Tat
/note="Protein Tat from Human immunodeficiency virus type 1
group M subtype B (isolate WMJ22). Accession#: P12509"
misc_feature 2027..2144
/label=cPPT/CTS
/note="central polypurine tract and central termination
sequence of HIV-1"
enhancer 2201..2504
/label=CMV enhancer
/note="human cytomegalovirus immediate early enhancer"
promoter 2505..2708
/label=CMV promoter
/note="human cytomegalovirus (CMV) immediate early
promoter"
misc_feature 2802..2867
/label=MCS
/note="multiple cloning site"
promoter 2890..3389
/label=PGK promoter
/note="mouse phosphoglycerate kinase 1 promoter"
CDS 3410..4006
/label=PuroR
/note="puromycin N-acetyltransferase"
misc_feature 4023..4611
/label=WPRE
/note="woodchuck hepatitis virus posttranscriptional
regulatory element"
LTR 4818..5451
/label=5' LTR
/note="5' long terminal repeat (LTR) from HIV-1"
primer_bind complement(5580..5596)
/label=M13 rev
/note="common sequencing primer, one of multiple similar
variants"
protein_bind complement(5604..5620)
/label=lac operator
/note="The lac repressor binds to the lac operator to
inhibit transcription in E. coli. This inhibition can be
relieved by adding lactose or
isopropyl-beta-D-thiogalactopyranoside (IPTG)."
promoter complement(5628..5658)
/label=lac promoter
/note="promoter for the E. coli lac operon"
protein_bind complement(5673..5694)
/label=CAP binding site
/note="CAP binding activates transcription in the presence
of cAMP."
rep_origin complement(5982..6570)
/direction=LEFT
/label=ori
/note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
replication"
CDS complement(6744..7601)
/label=AmpR
/note="beta-lactamase"
promoter complement(7602..7706)
/label=AmpR promoter
polyA_signal 7754..7888
/label=SV40 poly(A) signal
/note="SV40 polyadenylation signal"